Cargando…
A recurrence of advanced malignant sex cord tumor with annular tubules: case report
Sex cord tumor with annular tubules (SCTAT) is a rare special type of ovarian sex cord-stromal tumor, which has not achieved a standard treatment regimen currently. The aim of this report was to provide possible reference for treatment and supervision of recurrent advanced malignant SCTAT. A 33-year...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797714/ https://www.ncbi.nlm.nih.gov/pubmed/35117561 http://dx.doi.org/10.21037/tcr.2019.12.56 |
_version_ | 1784641618527125504 |
---|---|
author | Zheng, Ping Leng, Jinhua Lang, Jinghe |
author_facet | Zheng, Ping Leng, Jinhua Lang, Jinghe |
author_sort | Zheng, Ping |
collection | PubMed |
description | Sex cord tumor with annular tubules (SCTAT) is a rare special type of ovarian sex cord-stromal tumor, which has not achieved a standard treatment regimen currently. The aim of this report was to provide possible reference for treatment and supervision of recurrent advanced malignant SCTAT. A 33-year-old unmarried female with malignant SCTAT emerged recurrence after the cytoreductive surgery but preserved fertility and postoperative chemotherapy (3 cycles PEB regimens) 12 months. She was performed preoperative adjuvant chemotherapy (3 cycles, paclitaxel liposome and nedaplatin) before the third operation of secondary cytoreductive surgery, followed by platinum-based chemotherapy (7 cycles, TC regimens) timely because of dissatisfactory efficacy under the evaluation in combination with prior comprehensive treatment and PET/CT. The surgical stage was IIIB. She acquired complete remission after therapy and needed to regularly follow up every 3–6 months for 2 years and every 6–12 months after 2 years. There was no evidence of malignant SCTAT recurrence at the follow-up 24 months past the third surgery. No abnormality was found in other examination indexes, and menstruation was regular. The regular supervision of the patient was continually performed. The diagnosis of recurrent advanced malignant SCTAT was established on history and final pathology examination, whose prognosis mainly depended on the appropriate strategy of surgery and chemotherapy regimens. The classical TC regimens could be considered if the efficacy of other chemotherapy regimens were unsatisfactory. Regular follow-up was essential. |
format | Online Article Text |
id | pubmed-8797714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87977142022-02-02 A recurrence of advanced malignant sex cord tumor with annular tubules: case report Zheng, Ping Leng, Jinhua Lang, Jinghe Transl Cancer Res Case Report Sex cord tumor with annular tubules (SCTAT) is a rare special type of ovarian sex cord-stromal tumor, which has not achieved a standard treatment regimen currently. The aim of this report was to provide possible reference for treatment and supervision of recurrent advanced malignant SCTAT. A 33-year-old unmarried female with malignant SCTAT emerged recurrence after the cytoreductive surgery but preserved fertility and postoperative chemotherapy (3 cycles PEB regimens) 12 months. She was performed preoperative adjuvant chemotherapy (3 cycles, paclitaxel liposome and nedaplatin) before the third operation of secondary cytoreductive surgery, followed by platinum-based chemotherapy (7 cycles, TC regimens) timely because of dissatisfactory efficacy under the evaluation in combination with prior comprehensive treatment and PET/CT. The surgical stage was IIIB. She acquired complete remission after therapy and needed to regularly follow up every 3–6 months for 2 years and every 6–12 months after 2 years. There was no evidence of malignant SCTAT recurrence at the follow-up 24 months past the third surgery. No abnormality was found in other examination indexes, and menstruation was regular. The regular supervision of the patient was continually performed. The diagnosis of recurrent advanced malignant SCTAT was established on history and final pathology examination, whose prognosis mainly depended on the appropriate strategy of surgery and chemotherapy regimens. The classical TC regimens could be considered if the efficacy of other chemotherapy regimens were unsatisfactory. Regular follow-up was essential. AME Publishing Company 2020-03 /pmc/articles/PMC8797714/ /pubmed/35117561 http://dx.doi.org/10.21037/tcr.2019.12.56 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Case Report Zheng, Ping Leng, Jinhua Lang, Jinghe A recurrence of advanced malignant sex cord tumor with annular tubules: case report |
title | A recurrence of advanced malignant sex cord tumor with annular tubules: case report |
title_full | A recurrence of advanced malignant sex cord tumor with annular tubules: case report |
title_fullStr | A recurrence of advanced malignant sex cord tumor with annular tubules: case report |
title_full_unstemmed | A recurrence of advanced malignant sex cord tumor with annular tubules: case report |
title_short | A recurrence of advanced malignant sex cord tumor with annular tubules: case report |
title_sort | recurrence of advanced malignant sex cord tumor with annular tubules: case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797714/ https://www.ncbi.nlm.nih.gov/pubmed/35117561 http://dx.doi.org/10.21037/tcr.2019.12.56 |
work_keys_str_mv | AT zhengping arecurrenceofadvancedmalignantsexcordtumorwithannulartubulescasereport AT lengjinhua arecurrenceofadvancedmalignantsexcordtumorwithannulartubulescasereport AT langjinghe arecurrenceofadvancedmalignantsexcordtumorwithannulartubulescasereport AT zhengping recurrenceofadvancedmalignantsexcordtumorwithannulartubulescasereport AT lengjinhua recurrenceofadvancedmalignantsexcordtumorwithannulartubulescasereport AT langjinghe recurrenceofadvancedmalignantsexcordtumorwithannulartubulescasereport |